Discontinuation report M-EZETIMIBE
Report ID | 108914 |
Drug Identification Number | 02467437 |
Brand name | M-EZETIMIBE |
Common or Proper name | Ezetimibe |
Company Name | MANTRA PHARMA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2020-04-01 |
Actual discontinuation date | 2020-04-07 |
Remaining supply date | 2020-04-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Switch to another format (blister of 30 tablets) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-04-08 | French | Compare |
v5 | 2020-04-07 | French | Compare |
v4 | 2020-04-07 | English | Compare |
v3 | 2020-04-07 | English | Compare |
v2 | 2020-03-18 | French | Compare |
v1 | 2020-03-18 | English | Compare |
Showing 1 to 6 of 6